Company's collaborative partnership with IRICoR, Université de Montréal and MaRS Innovation, funded by Merck Canada, to advance macrocycle drug
TORONTO and MONTREAL, Nov. 10, 2014 — Encycle Therapeutics Inc., a biotechnology start-up founded by Dr. Andrei Yudin of the University of Toronto in partnership with MaRS Innovation, is developing its lead orally-bioavailable macrocycle drug to target integrin a4b7, which is involved in the inflammatory process in a number of diseases, most notably for inflammatory bowel disease.
This announcement was covered in SciBX, Drug Discovery ...
UTEST among the four U of T entrepreneurship programs to be funded through Ontario's CLA program
The University of Toronto will receive $3,056,000 in funding over two years from the Ontario government to increase its training and support for student entrepreneurship.
The funding is part of the Campus-Linked Accelerator Program (CLA), announced today by Reza Moridi, Ontario’s Minister of Research and Innovation, and Minister of Training, Colleges and Universities.
“Fostering the entrepreneurial spirit among students is a key component of Ontario’s Youth Jobs Strategy, ...
This story appears courtesy of our colleagues at U of T Engineering News.
While some of us are using the new power of 3D printers to make smartphone cases and chocolate figurines, two engineering students from the University of Toronto are using them to print functional human skin.
On September 18, Arianna McAllister and Lian Leng were named the Canadian winners of the 2014 James Dyson Award for their invention, the PrintAlive Bioprinter.
This story was covered by CBC News and BBC News. The BioPrinter ...
Encycle Therapeutics, a MaRS Innovation start-up company from the University of Toronto, was featured in a BioCentury emerging company profile by Michael J. Haas.
The company is currently raising a Series A financing round and employs eight people.
Haas' profile, "Encycle: Oral Macrocycles," is available behind a pay wall on the BioCentury website.
Here's a short excerpt:
Macrocycle therapies can block protein-protein interactions that are undruggable with small molecules; however, oral availability and cell penetration remain key challenges. Encycle Therapeutics Inc.’s chemistry platform generates drug-like ...
UTEST graduate Whirlscape, makers of the wearable, one-line Minuum keyboard, were recently featured on CBC's Lang and O'Leary Exchange.
Minuum has also broken the 100 billion pixels mark in screen space saved for its users. Read about it on input, the Minuum blog.
Founder and CEO Will Walmsley was interviewed by Amanda Lang. The footage was also made available on CBC News, and was included in CBC's weekly summary of the week's top business stories. Watch the video.
Here's an excerpt:
Typing on a smartphone ...
TORONTO, July 14, 2014 - Xagenic Inc., a molecular diagnostics company developing the first lab-free molecular diagnostic platform with a 20 minute time-to-result, has announced a second closing of its recently announced Series B financing, bringing the total raised in this round to $25.5 million.
In conjunction with this closing, new investor BDC Capital joined as an investor and Dion Madsen, senior managing partner at BDC Capital, will join Xagenic's Board of Directors.
From our archives: MaRS Innovation's lead start-up completes $20 million ...
Jeff Cates' op-ed in the Globe and Mail's Small Business/Digital Innovation section on June 19, 2014 argues that incubators have a key role to play in fostering innovation, entrepreneurship and growing new industries in Ontario.
Cates states this is particularly true when incubators when they provide programs and services to help young entrepreneurs succeed.
The University of Toronto Early-Stage Technology program (UTEST), co-managed with MaRS Innovation, is one such program. UTEST is set to announce its third cohort within the next month.
New research emerging from the University of Toronto's Edward S Rogers Sr. Department of Electrical and Computer Engineering is developing and demonstrating a new class of solar-sensitive nanoparticle.
MaRS Innovation is working with Professor Ted Sargent, his research team and U of T's Innovations and Partnerships Office (IPO) to incubate and commercialize this and other solar technologies. Their work was recently published in Nature Materials.
The paper's publication was widely covered in the technical trades, including CNET.com, Tech Times, Compound Semiconductor.net and ...
MaRS Innovation and U of T's Innovations & Partnerships Office collaborating with QSperm on intellectual property and business strategy
In vitro fertility treatments can be intensely emotional and medically invasive, not to mention expensive.
But technical developments from a research group at the University of Toronto may soon be able to shorten the journey to pregnancy – and that potential has piqued interest from international investors.
The research group, QSperm, is looking to turn their research into a biotech start-up leveraging an innovative sperm sorting design ...